Actively Recruiting

Age: 18Years - 80Years
FEMALE
NCT05709769

Radiomics-based Malnutrition for Cervical Cancer.

Led by Zhejiang Provincial People's Hospital · Updated on 2023-07-20

150

Participants Needed

1

Research Sites

204 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Loss of skeletal muscle, is one of the most prevalent symptoms of malnutrition, and has been frequently reported as a negative factor in cancer patients at any disease stage. In this study, we are planning to firstly analyze the radiomics features of psoas extracted at the level of the third lumbar vertebra (L3) and then, develop a CT-based radiomics nomogram prediction model for predicting malnutrition based on their Patient-Generated Subjective Global Assessment (PG-SGA) scores in patients with International Federation of Gynecology and Obstetrics (FIGO, 2014 version) stage IB1-IIA2 cervical cancer (CC) who received postoperative radiotherapy/chemoradiotherapy (RT/CRT).

CONDITIONS

Official Title

Radiomics-based Malnutrition for Cervical Cancer.

Who Can Participate

Age: 18Years - 80Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients who had pelvic lymphadenectomy and radical hysterectomy with pathological diagnosis of cervical cancer
  • Patients with stage IB1-IIA2 cervical cancer according to the 2014 FIGO staging system
  • Patients who received postoperative radiotherapy or chemoradiotherapy within one week after admission
  • Patients with Eastern Cooperative Oncology Group performance status between 0 and 2
  • Patients without prior treatments before radical surgery
  • Patients with normal bone marrow function and recent blood tests meeting defined thresholds
  • Patients without allergy to platinum-based chemotherapy drugs
  • Patients willing to comply with nutritional therapy
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • Poor quality CT images or visible artifacts around the L3 psoas muscle
  • Prior chemotherapy or radiation treatments
  • Poor bone marrow, liver, or kidney function that would prevent tolerating therapy
  • Participation in other clinical trials
  • Pregnancy, breastfeeding, or not using birth control
  • Major uncontrolled medical conditions such as active infections, serious heart conditions, psychiatric illness, or social issues limiting compliance
  • History of another active cancer within the past five years
  • Poor image quality or visible artifacts around the L3 psoas muscle

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Zhejiang Provincial People's Hospital

Hangzhou, Zhejiang, China, 310000

Actively Recruiting

Loading map...

Research Team

H

Hong'en Xu, M.D.

CONTACT

H

Huafeng Shou, M.D.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here